Diane Lewis Horowitz, MD

Director, The Rheumatoid Arthritis Center, Northwell Health

Director, Rheumatology Continuing Medical Education, Northwell Health

Assistant Professor of Medicine, Hofstra Northwell School of Medicine

Phone: (516) 708-2550
Email: dhorowitz@northwell.edu

About the Investigator

Dr. Horowitz is involved with both NIH and industry sponsored research.

Research Focus

Rheumatoid Arthritis Novel Therapeutics
Comparative effectiveness
Medical decision making
Rheumatoid Arthritis therapeutic use
Shared decision making
Bone Health in Rheumatoid Arthritis
Research Specialty: Rheumatology

Education

North Shore-LIJ Medical Center, New York Univeristy
Degree: Fellowship
2010

St. Vincent’s Catholic Medical Center, New York College of Medicine
Degree: Chief Resident
2008

St. Vincent’s Catholic Medical Center, New York College of Medicine
Degree: Residency
2007

State Univeristy of New York at Stony Brook College of Medicine
Degree: MD
2004

Univeristy of Pennsylvania
Degree: BA
2000

Honors and Awards

2000 BA Cum Laude

Publications
  1. Horowitz, DL, Furie, RA. “Belimumab is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making?” Curr Rheumatol Rep. 2012 DOI 10.1007/s11926-012-0256-4
  2. Horowitz, DL, Furie, RA. “Does Belimumab Reduce Disease Activity in Adults with Systemic Lupus Erythrematosus?” Clinical Medicine Reviews in Therapeutics. 2012:4 71-78.
  3. Horowitz, DL, Katzap, E, Horowtiz, S, Barilla-LaBarca, ML. “Approach to septic Arthritis.” Am Fam Physician. 84(6): 653-60. 2011.
  4. Horowitz, DM and Furie, RA. “Abetimus Sodium: A Medication for the Prevention of Lupus Nephritis Flares.” Expert Opinion Pharmacotherapy. 10(9): 1501-7. 2009.
  5. Korutla L, Wang PJ, Lewis DM, Neustadter JH, Stromberg MF, and Mackler SA. “Differences in Expressions, Actions and Cocaine Regulation of Two Isoforms for the Brain Transcriptional Regulator NAC-1.” Neuroscience. 110(3): 421-9, 2002.

View more at PubMed